- Nachrichtendetail
-
21.05.2024 13:19:02 - dpa-AFX: *HALOZYME: BRISTOL MYERS SQUIBB GETS UPDATED ACTION DATE OF DEC. 29 FOR SUBCUTANEOUS NIVOLUMAB CO-FORMULATED WITH ENHANZE
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Bristol-Myers Squibb Co | 850501 | NYSE | 48,250 | 31.07.24 20:02:12 | -0,800 | -1,63% | 48,250 | 48,260 | 48,750 | 49,050 |
